C R Bard Newswire (Page 2)

C R Bard Newswire (Page 2)

Comprehensive Real-Time News Feed for C R Bard. (Page 2)

Results 21 - 40 of 2,166 in C R Bard

  1. C.R. Bard (BCR) vs. Baxter International (BAX) Head-To-Head ContrastRead the original story w/Photo

    Tuesday Dec 5 | AmericanBankingNews.com

    C.R. Bard and Baxter International are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Baxter International has higher revenue and earnings than C.R. Bard.

    Comment?

  2. Drug Eluting Balloons Market Is Expected to Continue Flourishing in...Read the original story w/Photo

    Tuesday Dec 5 | SBWire

    Restenosis prevention continues to be a major challenge for the interventional cardiologists. This is because of inevitable limitations of the present technologies or therapies in preventing the recurrence of stenosis .

    Comment?

  3. 1,100 Shares in C.R. Bard, Inc. (BCR) Purchased by FDO Partners LLCRead the original story w/Photo

    Tuesday Dec 5 | Daily Political

    FDO Partners LLC acquired a new stake in shares of C.R. Bard, Inc. in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,100 shares of the medical instruments supplier's stock, valued at approximately $353,000.

    Comment?

  4. Wall Street Banks Eye a $600 Million Payday on CVS, Aetna DealRead the original story w/Photo

    Monday Dec 4 | Bloomberg

    Wall Street banks including Barclays, Goldman Sachs and Bank of America could share in a fee bonanza of as much as $600 million, after pledging one of the biggest financing checks ever to help fund CVS's $67.5 billion The companies are set to shell out fees for M&A advisory, financing and also arranging a bond sale next year to replace a $40 billion bridge loan from the three banks. Banks providing that loan could split up to $150 million, while underwriters on any debt sale could extract around $200 million combined, according to Freeman Consulting Services.

    Comment?

  5. ValuEngine Lowers C.R. Bard (BCR) to HoldRead the original story w/Photo

    Monday Dec 4 | IntersportsWire

    Several other analysts have also commented on BCR. Jefferies Group reiterated a hold rating on shares of C.R. Bard in a research report on Thursday, August 3rd.

    Comment?

  6. Stifel Financial Corp Has $48.25 Million Stake in C.R. Bard, Inc.Read the original story w/Photo

    Monday Dec 4 | Daily Political

    Stifel Financial Corp decreased its stake in shares of C.R. Bard, Inc. by 18.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 150,445 shares of the medical instruments supplier's stock after selling 34,941 shares during the period.

    Comment?

  7. Biopsy Devices Market is estimated to be growing at a CAGR of 7.4% during the forecast periodRead the original story w/Photo

    Monday Dec 4 | PR-inside.com

    Biopsy Devices Market by Product, by Type, by Application, and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts According to the report Biopsy Devices Market, published by Market Data Forecast, the global market is projected to reach USD 2214.89 million by 2021, at a CAGR of 7.4% from 2016 to 2021. Get accurate market forecast and analysis on the Biopsy Devices Market.

    Comment?

  8. Global IV Equipment Market -Professional Survey Report 2017Read the original story w/Photo

    Sunday Dec 3 | PR-inside.com

    Global IV Equipment Market is worth USD 9 billion in 2016 and estimated to grow at a CAGR of 6.2%, to reach USD12.16 billion by 2021. The global IV Equipment market is developing at an exceptionally quick pace.

    Comment?

  9. Asia Pacific Breast Biopsy Market Expected a Maintain 11.3% CAGR during 2016 to 2021Read the original story w/Photo

    Sunday Dec 3 | PR-inside.com

    Asia Pacific Breast Biopsy Market By Type , By Product , By Guidance And By Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts Asia Pacific Breast Biopsy Market was worth USD 87.28 million in 2016 and estimated to be growing at a CAGR of 11.3%, to reach USD 149.07 million by 2021. Browse details of 130 pages research report on Asia Pacific Breast Biopsy Market @ ..

    Comment?

  10. C.R. Bard (BCR) Downgraded to "Hold" at ValuEngineRead the original story w/Photo

    Sunday Dec 3 | AmericanBankingNews.com

    Other equities analysts have also recently issued research reports about the stock. Jefferies Group restated a "hold" rating on shares of C.R. Bard in a research report on Thursday, August 3rd.

    Comment?

  11. Comparing Ocular TherapeutixRead the original story w/Photo

    Saturday Dec 2 | Daily Political

    Ocular Therapeutix and C.R. Bard are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, analyst recommendations, profitability, earnings and risk. Ocular Therapeutix presently has a consensus price target of $20.67, indicating a potential upside of 414.10%.

    Comment?

  12. Financial Comparison: C.R. BardRead the original story w/Photo

    Saturday Dec 2 | AmericanBankingNews.com

    C.R. Bard and Sientra are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, valuation and analyst recommendations. 79.2% of C.R. Bard shares are owned by institutional investors.

    Comment?

  13. Zeke Capital Advisors LLC Takes Position in C.R. Bard, Inc.Read the original story w/Photo

    Saturday Dec 2 | Daily Political

    Zeke Capital Advisors LLC purchased a new position in shares of C.R. Bard, Inc. during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 1,057 shares of the medical instruments supplier's stock, valued at approximately $339,000.

    Comment?

  14. C.R. Bard, Inc. (BCR) To Go Ex-Dividend on December 7thRead the original story w/Photo

    Saturday Dec 2 | Daily Political

    C.R. Bard, Inc. declared a quarterly dividend on Wednesday, October 11th, RTT News reports. Investors of record on Friday, December 8th will be paid a dividend of 0.26 per share by the medical instruments supplier on Friday, December 29th.

    Comment?

  15. C.R. Bard, Inc. (BCR) Stake Increased by Legal & General Group PlcRead the original story w/Photo

    Friday Dec 1 | IntersportsWire

    Legal & General Group Plc lifted its stake in shares of C.R. Bard, Inc. by 2.0% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 380,832 shares of the medical instruments supplier's stock after acquiring an additional 7,568 shares during the quarter.

    Comment?

  16. Snow Capital Management LP Increased Mellanox Technologies LTD (MLNX) ...Read the original story

    Friday Dec 1 | Hill Country Times

    CR Bard Incorporated had an increase of 8.9% in short interest. BCR's SI was 1.22M shares in December as released by FINRA.

    Comment?

  17. By 2021, Angioplasty Balloons Market to Reach Approximately US $2.41 BnRead the original story w/Photo

    Thursday Nov 30 | SBWire

    Zion Market Research has published a new report titled "Angioplasty Balloons Market by Product Market by Material : Global Industry Perspective, Comprehensive Analysis, and Forecast, 2015 - 2021". According to the report, global demand for angioplasty balloons market was valued at around USD 1.95 billion in 2015 and is expected to generate revenue of around USD 2.41 billion by end of 2021, growing at a CAGR of around 4.3% between 2016 and 2021.

    Comment?

  18. Global Vascular Graft Market Will Be US $3.29 Bn During 2016-2024Read the original story w/Photo

    Thursday Nov 30 | SBWire

    This report on the vascular graft market analyzes the current and future scenario of the global market. Large number of cardiovascular disease patient and diabetes sufferers is increasing the usage of vascular grafts.

    Comment?

  19. Europe holds the second major market for biopsy devicesRead the original story w/Photo

    Thursday Nov 30 | PR-inside.com

    Europe Biopsy Devices Market by Product, by Type, by Application, and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts As per the syndicated report published by Market Data Forecast Europe Biopsy devices Market which is estimated to be USD 449.5 million in 2016 is poised to reach USD 633.4 million by 2021, at a CAGR of 7.10% from 2016 to 2021. It can attributed to the factors such as the quickly aging population and a parallel increase in the incidence of cancer.

    Comment?

  20. Skandinaviska Enskilda Banken AB publ Sells 4,000 Shares of C.R. Bard, Inc.Read the original story w/Photo

    Thursday Nov 30 | IntersportsWire

    Skandinaviska Enskilda Banken AB publ trimmed its holdings in C.R. Bard, Inc. by 3.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 131,423 shares of the medical instruments supplier's stock after selling 4,000 shares during the period.

    Comment?